Literature DB >> 17293538

A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres.

Daniela Rossi1, Patrick De Smet, Alla Lyfenko, Lucia Galli, Stefania Lorenzini, Daniela Franci, Francesco Petrioli, Alfredo Orrico, Corrado Angelini, Vincenzo Tegazzin, Robert Dirksen, Vincenzo Sorrentino.   

Abstract

A novel single-nucleotide deletion in exon 100 of the RYR1 gene, corresponding to deletion of nucleotide 14,510 in the human RyR1 mRNA (c14510delA), was identified in a man with malignant hyperthermia and in his two daughters who were normal for malignant hyperthermia. This deletion results in a RyR1 protein lacking the last 202 amino acid residues. All three subjects heterozygotic for the mutated allele presented with a prevalence of type 1 fibres with central cores, although none experienced clinical signs of myopathy. Expression of the truncated protein resulted in non-functional RYR1 calcium release channels. Expression of wild-type and RyR1(R4836fsX4838) proteins resulted in heterozygotic release channels with overall functional properties similar to those of wild-type RyR1 channels. Nevertheless, small differences in sensitivity to calcium and caffeine were observed in heterotetrameric channels, which also presented an altered assembly/stability in sucrose-gradient centrifugation analysis. Altogether, these data suggest that altered RYR1 tetramer assembly/stability coupled with subtle chronic changes in Ca2+ homoeostasis over the long term may contribute to the development of core lesions and incomplete malignant hyperthermia susceptibility penetrance in individuals carrying this novel RYR1 mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293538      PMCID: PMC2598062          DOI: 10.1136/jmg.2006.043794

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2+) channel.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

2.  Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2001-09       Impact factor: 4.086

3.  Carboxyl-terminal sequences critical for inositol 1,4,5-trisphosphate receptor subunit assembly.

Authors:  Daniel L Galvan; Gregory A Mignery
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

4.  An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.

Authors:  N Monnier; N B Romero; J Lerale; Y Nivoche; D Qi; D H MacLennan; M Fardeau; J Lunardi
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

5.  A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia.

Authors:  Nicole Monnier; Ana Ferreiro; Isabelle Marty; Annick Labarre-Vila; Paulette Mezin; Joel Lunardi
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

6.  Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.

Authors:  Tianzhong Yang; Tram Anh Ta; Isaac N Pessah; Paul D Allen
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

7.  Oligomerization of the cardiac ryanodine receptor C-terminal tail.

Authors:  Richard Stewart; Spyros Zissimopoulos; F Anthony Lai
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

8.  Ryanodine receptor regulation by intramolecular interaction between cytoplasmic and transmembrane domains.

Authors:  Christopher H George; Hala Jundi; N Lowri Thomas; Mark Scoote; Nicola Walters; Alan J Williams; F Anthony Lai
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

9.  Calmodulin binding to the 3614-3643 region of RyR1 is not essential for excitation-contraction coupling in skeletal myotubes.

Authors:  Kristen M S O'Connell; Naohiro Yamaguchi; Gerhard Meissner; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2002-09       Impact factor: 4.086

10.  RyR1 and RyR3 isoforms provide distinct intracellular Ca2+ signals in HEK 293 cells.

Authors:  Daniela Rossi; Ilenia Simeoni; Marcella Micheli; Martin Bootman; Peter Lipp; Paul D Allen; Vincenzo Sorrentino
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

View more
  5 in total

1.  Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum.

Authors:  Diana Xerxes Bharucha-Goebel; Mariarita Santi; Livija Medne; Kristen Zukosky; Kristin Zukosky; Jahannaz Dastgir; Perry B Shieh; Thomas Winder; Gihan Tennekoon; Richard S Finkel; James J Dowling; Nicole Monnier; Carsten G Bönnemann
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

2.  Congenital myopathies in the adult neuromuscular clinic: Diagnostic challenges and pitfalls.

Authors:  Stefan Nicolau; Teerin Liewluck; Jennifer A Tracy; Ruple S Laughlin; Margherita Milone
Journal:  Neurol Genet       Date:  2019-06-04

Review 3.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

4.  Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.

Authors:  Ilaria Genovese; Flavia Giamogante; Lucia Barazzuol; Theo Battista; Annarita Fiorillo; Mattia Vicario; Giuseppina D'Alessandro; Raffaela Cipriani; Cristina Limatola; Daniela Rossi; Vincenzo Sorrentino; Elena Poser; Luciana Mosca; Ferdinando Squitieri; Marzia Perluigi; Andrea Arena; Filip van Petegem; Claudia Tito; Francesco Fazi; Carlotta Giorgi; Tito Calì; Andrea Ilari; Gianni Colotti
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

Review 5.  Malignant hyperthermia.

Authors:  Henry Rosenberg; Mark Davis; Danielle James; Neil Pollock; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2007-04-24       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.